
MEDIROM Healthcare Technologies Inc.: financial statements
Price
$0.23
November 20, 2026Market cap $1.8M
What Ploutos Investor adds for MEDIROM Healthcare Technologies
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The debt we can read is far below what the company's own annual report says falls due over the coming years, so most of its borrowing is in figures we cannot read. We leave out the debt, net cash, enterprise value and the multiples built on them.
Financial statements
Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.
Click a line to see it on the chart.
Revenue
+1.1% a year over 2 years
| Line | 2023 | 2024 | 2025 | Average a year |
|---|---|---|---|---|
| Revenue | $48M | $53M | $50M | +1.1% |
| Cost of revenue | $37M | $38M | – | |
| Gross profit | $11M | $14M | – | |
| Operating income | -$2.8M | -$115.0K | -$22M | |
| Net income | $818.9K | $945.3K | -$23M | |
| Earnings per share | $0.16 | $0.18 | -$2.93 | |
| Earnings per share, basic | $0.17 | $0.19 | -$2.93 | |
| Margins | ||||
| Gross margin | 23.0% | 27.1% | – | |
| Operating margin | -5.7% | -0.2% | -43.7% | |
| Net margin | 1.7% | 1.8% | -46.8% | |
Financial statements
MRM's revenue, profits and cash flows from 2019 to 2022, 4 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
By segment
Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.
- Relaxation Salon
- Luxury Beauty
- Digital Preventative Healthcare
- 2022: Relaxation Salon $45M, Luxury Beauty $4.5M, Digital Preventative Healthcare $2.9M
- 2023: Relaxation Salon $43M, Luxury Beauty $4.0M, Digital Preventative Healthcare $1.4M
- 2024: Relaxation Salon $47M, Luxury Beauty $4.4M, Digital Preventative Healthcare $976.3K
| Segment | 2022 | 2023 | 2024 | Share 2024 |
|---|---|---|---|---|
| Relaxation Salon | $45M | $43M | $47M | 90% |
| Luxury Beauty | $4.5M | $4.0M | $4.4M | 8.4% |
| Digital Preventative Healthcare | $2.9M | $1.4M | $976.3K | 1.9% |
By segment
MRM's revenue by segment from 2019 to 2021, 3 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
From the XBRL of 5 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.
Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.
Debt and obligations
What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.
The debt we can read is far below what the company's own annual report says falls due over the coming years, so most of its borrowing is in figures we cannot read. We leave out the debt, net cash, enterprise value and the multiples built on them.
When the debt falls due
Dec 31, 2024Due within 2 years
$715M
Total falling due
$1.4B
Total in the ladder $1.4B, from the annual report dated December 31, 2024. Principal of loans and bonds, without leases and interest. The filing
- 2025: $621M
- 2026: $95M
- 2027: $395M
- 2028: $95M
- 2029: $93M
- 2030 on: $87M
The ladder at each year end
| Year | 1 yr | 2 yrs | 3 yrs | 4 yrs | 5 yrs | Later |
|---|---|---|---|---|---|---|
| 2024 | $621M | $95M | $395M | $95M | $93M | $87M |
| 2023 | $100M | $87M | $95M | $595M | $95M | $180M |
| 2022 | $99M | $96M | $68M | $54M | $554M | $377M |
The ladder at each year end
When MRM's debt fell due, as each annual report set it out, from 2020 to 2021, 2 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Leases
Dec 31, 2024Operating leases
$2.1B
Finance leases
–
- Average discount rate
- 2.3%
The liability is the present value of the rent still to pay, at December 31, 2024. It is not counted in the ladder's debt. The filing
Operating lease payments by year
Lease liability by year
Goodwill by segment
Dec 31, 2024Total goodwill
$389M
The company does not state its goodwill by segment, at December 31, 2024. The filing
Goodwill by year
Goodwill by year
MRM's goodwill from 2020 to 2021, 2 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
From the statutory to the effective tax rate, 2024
Dec 31, 2024Statutory rate
30.6%
Effective rate
-189.6%
The company paid -189.6% in tax on its profit, 220.2 points below the statutory rate it starts from (30.6%). Below, the reasons it gives.
Statutory rate
30.6%
Inhabitant Tax
+22.0 pts
Difference In Tax Rate Of Subsidiary
+13.8 pts
Non-deductible expenses
+6.1 pts
Change in tax law
+0.1 pts
Change in valuation allowance
-260.7 pts
Other
-1.5 pts
Effective rate
-189.6%
One point is 1% of profit before tax. The lines are as the company states them in the notes to its annual report. The filing
Effective tax rate by year
In a year of a loss or of very small profits the rate comes out negative or very large and says little. Those years are in grey.
Effective tax rate by year
The tax rate MRM paid on its profit, from 2019 to 2021, 3 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Claims ahead of shareholders
What stands between the business and its shareholders besides the debt, and the financial assets on the other side, from the latest balance sheet.
$2.8M of other claims rank ahead of the shares, about 152% of the market value.
Ahead of the shares
- at Dec 31, 2025
- $309.2K
- at Dec 31, 2025
- $2.5M
From the balance sheet of December 31, 2025. The retirement and environmental lines and the pension deficit come from the latest annual report when the quarter's filing does not state them, each with its own date. Market value at the price of November 20, 2026. A line is listed when it is at least 0.5% of the market value. A description of the balance sheet, not a valuation.
The metrics a company reports about itself (users, stores, subscribers) are read for S&P 500 companies only.
The full analysis
What do MEDIROM Healthcare Technologies's filings show?
These are MEDIROM Healthcare Technologies's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
How much revenue did MRM have in 2025?
MEDIROM Healthcare Technologies had revenue of $50M and net income of -$23M in fiscal 2025, a net margin of -46.8%.
How much debt does MRM have?
On December 31, 2025 MEDIROM Healthcare Technologies had total assets of $30M, debt of $6.1M and shareholders' equity of -$17M.
How much free cash flow does MRM have?
In fiscal 2025 MEDIROM Healthcare Technologies had cash from operations of -$7.4M and spent $65.7K on capital expenditure, leaving -$7.4M of free cash flow.
Where are the figures from?
From MEDIROM Healthcare Technologies Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.